HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance.

Abstract
A large family with a history of hereditary chemodectoma has been successfully screened by means of radionuclide scintiangiography. This procedure could restrict selective and more invasive roentgenangiography only to those cases in which flow patterns are abnormal. Three asymptomatic cases of chemodectoma were revealed by this method. Early therapeutic measures may now be feasible. We discuss the possibilities for surveillance of these families without causing discomfort to the group involved.
AuthorsJ E Veldman, P H Mulder, S H Ruijs, G de Haas, P F van Waes, A Hoekstra
JournalArchives of otolaryngology (Chicago, Ill. : 1960) (Arch Otolaryngol) Vol. 106 Issue 9 Pg. 547-52 (Sep 1980) ISSN: 0003-9977 [Print] United States
PMID6250521 (Publication Type: Journal Article)
Chemical References
  • Diphosphonates
  • Technetium
  • Technetium Tc 99m Medronate
Topics
  • Adolescent
  • Adult
  • Aged
  • Carotid Arteries (diagnostic imaging)
  • Diphosphonates
  • Female
  • Head and Neck Neoplasms (complications, diagnostic imaging, genetics)
  • Humans
  • Male
  • Methods
  • Middle Aged
  • Paraganglioma, Extra-Adrenal (complications, diagnostic imaging, genetics)
  • Paralysis (etiology)
  • Pedigree
  • Radionuclide Imaging
  • Technetium
  • Technetium Tc 99m Medronate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: